Follow the Tevogen Bio Holdings Inc. share price and the full insider trade history of the company, a listed issuer based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). Market capitalisation: €29m. The latest transaction was disclosed on 10 July 2026 (Attribution). Among the most active insiders: Saadi Ryan H.. All data is accessible without an account.
37
Insider Decl.
n/a
Thresholds
€4,114
2 ops.
Buy Volume
€3m
6 ops.
Sell Volume
30Σ signal
Buys €4,114€3m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Tevogen Bio Holdings Inc. is a biotechnology company focused on developing T-cell therapies to treat viral diseases and cancers. It is listed on NASDAQ under the ticker TEVO.